These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20734396)

  • 1. How does initial treatment choice affect short-term and long-term costs for clinically localized prostate cancer?
    Snyder CF; Frick KD; Blackford AL; Herbert RJ; Neville BA; Carducci MA; Earle CC
    Cancer; 2010 Dec; 116(23):5391-9. PubMed ID: 20734396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing localized prostate cancer by radical prostatectomy or watchful waiting: Cost analysis of a randomized trial (SPCG-4).
    Andersson SO; Andrén O; Lyth J; Stark JR; Henriksson M; Adami HO; Carlsson P; Johansson JE
    Scand J Urol Nephrol; 2011 Apr; 45(3):177-83. PubMed ID: 21265595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term medical-care costs related to prostate cancer: estimates from linked SEER-Medicare data.
    Stokes ME; Black L; Benedict A; Roehrborn CG; Albertsen P
    Prostate Cancer Prostatic Dis; 2010 Sep; 13(3):278-84. PubMed ID: 20212521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenocarcinoma of the prostate: an expensive way to die.
    Piper NY; Kusada L; Lance R; Foley J; Moul J; Seay T
    Prostate Cancer Prostatic Dis; 2002; 5(2):164-6. PubMed ID: 12497008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer: a high value target for cost containment.
    Gomella LG
    Can J Urol; 2013 Oct; 20(5):6888. PubMed ID: 24128823
    [No Abstract]   [Full Text] [Related]  

  • 6. First-year costs of treating prostate cancer: estimates from SEER-Medicare data.
    Roehrborn CG; Albertsen P; Stokes ME; Black L; Benedict A
    Prostate Cancer Prostatic Dis; 2009; 12(4):355-60. PubMed ID: 19468284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilizing time-driven activity-based costing to understand the short- and long-term costs of treating localized, low-risk prostate cancer.
    Laviana AA; Ilg AM; Veruttipong D; Tan HJ; Burke MA; Niedzwiecki DR; Kupelian PA; King CR; Steinberg ML; Kundavaram CR; Kamrava M; Kaplan AL; Moriarity AK; Hsu W; Margolis DJ; Hu JC; Saigal CS
    Cancer; 2016 Feb; 122(3):447-55. PubMed ID: 26524087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment costs of localized prostate cancer in Germany : Economic results from the HAROW observational study].
    Reinhold T; Dornquast C; Börgermann C; Weißbach L
    Urologe A; 2016 Dec; 55(12):1573-1585. PubMed ID: 27822603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technological changes in the management of prostate cancer result in increased healthcare costs--a retrospective study in a defined Swedish population.
    Sennfält K; Carlsson P; Thorfinn J; Frisk J; Henriksson M; Varenhorst E
    Scand J Urol Nephrol; 2003; 37(3):226-31. PubMed ID: 12775282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term mortality with localized prostate cancer.
    Merglen A; Schmidlin F; Fioretta G; Verkooijen HM; Rapiti E; Zanetti R; Miralbell R; Bouchardy C
    Arch Intern Med; 2007 Oct; 167(18):1944-50. PubMed ID: 17923593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective analysis illustrating the substantial clinical and economic burden of prostate cancer.
    Crawford ED; Black L; Eaddy M; Kruep EJ
    Prostate Cancer Prostatic Dis; 2010 Jun; 13(2):162-7. PubMed ID: 20125121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost comparison between watchful waiting with active surveillance and active treatment of clinically localized prostate cancer.
    Corcoran AT; Peele PB; Benoit RM
    Urology; 2010 Sep; 76(3):703-7. PubMed ID: 20381846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model.
    Grover SA; Coupal L; Zowall H; Rajan R; Trachtenberg J; Elhilali M; Chetner M; Goldenberg L
    CMAJ; 2000 Apr; 162(7):977-83. PubMed ID: 10763395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cumulative cost pattern comparison of prostate cancer treatments.
    Wilson LS; Tesoro R; Elkin EP; Sadetsky N; Broering JM; Latini DM; DuChane J; Mody RR; Carroll PR
    Cancer; 2007 Feb; 109(3):518-27. PubMed ID: 17186528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial treatment costs of organ-confined prostate cancer: a general perspective.
    Kommu SS; Eden CG; Luscombe CJ; Golash A; Persad RA
    BJU Int; 2011 Jan; 107(1):1-3. PubMed ID: 21176067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of additional treatment for prostate cancer after radical prostatectomy, radiation therapy, androgen deprivation, or watchful waiting.
    Berge V; Thompson T; Blackman D
    Scand J Urol Nephrol; 2007; 41(3):198-203. PubMed ID: 17469027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conventional treatments of localized prostate cancer.
    Zerbib M; Zelefsky MJ; Higano CS; Carroll PR
    Urology; 2008 Dec; 72(6 Suppl):S25-35. PubMed ID: 19095125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geographic and socioeconomic variation in the treatment of prostate cancer.
    Krupski TL; Kwan L; Afifi AA; Litwin MS
    J Clin Oncol; 2005 Nov; 23(31):7881-8. PubMed ID: 16204005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cost and efficacy of treatment strategies in localized prostatic cancer: feasibility study in the general population].
    Bauvin E; Molinier L; Dervaux B; Soulié M; Latorzeff I; Bachaud JM; Villers A; Elias A; Grosclaude P
    Prog Urol; 2003 Sep; 13(4):618-23. PubMed ID: 14650293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
    Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.